Complain about a product or service

Antidepressant Benefits May Outweigh Risks: Study

April 18, 2007

• Black Box Warning Linked to Suicide Spike • Study Finds Lessened Suicide Risk in Young Adults on Antidepressants • Antidepressant Benefits May Outweigh Suicide Risks: Study • Firearms Stored Less Safely in Homes With Older Children • Study Links Anti-Depressants, Youth Suicide • Study Suggests Antidepressant-Suicide Link • FDA Issues Suicide Warning on ADHD Drug • Study Finds Stronger Link Between Paxil And Suicide • Former Prozac Users Slam FDA • FDA Updates Analysis of Prozac in Children • FDA Beefs Up Antidepressant Safeguards for Children

A review of previous studies indicates that the benefits of antidepressants for children and teens with depression or anxiety disorders may outweigh their risks, and that the increased risk for suicidal thoughts and attempts from using these medications is not statistically significant, according to an article in the April 18 issue of JAMA.

Previous research has indicated that the usage of antidepressants among children and adolescents is associated with an increased risk for suicidal behavior and thoughts, and resulted in the issuing of mandated label warnings on pediatric antidepressant medications by the FDA, according to background information in the article.

Jeffrey A. Bridge, Ph.D., of The Ohio State University, Columbus, and colleagues conducted a review and meta-analysis of randomized controlled trials involving the pediatric usage of antidepressants for major depressive disorder (MDD), obsessive-compulsive disorder (OCD), and non-OCD anxiety disorders, and included recent trials that had not been incorporated into previous analyses, to assess their benefits and effect on risk of suicidal thoughts and attempts.

The researchers conducted a search for studies through 2006 and identified and included 27 pediatric trials for their analysis.

The researchers said they found that, consistent with the FDA's findings, "We found evidence of an overall small but increased risk of treatment -- emergent suicidal ideation/suicide attempt.

"However, the pooled random-effects risk differences of suicidal ideation/suicide attempt for each indication were all less than 1 percent. There were no completed suicides in these trials."

Adolescents appeared to respond better than children to antidepressants in trials of both depression and anxiety.

"Some may argue that any risk of suicidal ideation/suicide attempt cannot possibly justify treatment with antidepressants for children and adolescents," the authors wrote. "Instead, we believe that the strength of evidence presented here supports the cautious and well-monitored use of antidepressant medications as one of the first-line treatment options, with the recognition that efficacy appears greatest for non-OCD anxiety disorders, intermediate for OCD, and more modest for MDD.

"Since the choice of treatment should be the result of a collaborative discussion between clinician, family, and patient, the information presented in this report should allow for an informed evaluation of the potential benefits and risks of these medications vs. no treatment and provide a framework for their comparison with nondrug treatments as well," the researchers conclude.

Report Your Experience
If you've had a bad experience -- or a good one -- with a consumer product or service, we'd like to hear about it. All complaints are reviewed by class action attorneys and are considered for publication on our site. Knowledge is power! Help spread the word. File your consumer report now.